Expertise in
15
conditions

Jean-yves Y. Delattre

Paris, FR 
Expertise in
15
conditions
Paris, FR 

Overview

Jean-yves Delattre practices practicing medicine in Paris, France.

Delattre is highly rated in 15 conditions, according to our data. Their clinical expertise encompasses Glioma, Gliomatosis Cerebri, Astrocytoma, and Glioblastoma.

They are actively involved in clinical research, co-authoring 122 peer reviewed articles and participating in 3 clinical trials.

Locations

Paris, France
Other Locations
Lille, 59000, France
Foix, France
Lyon, France
Université Paris Est, INSERM U955, Et Fondation FondaMental, Creteil, France
Marseille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized Trial of Delayed Radiotherapy in Patients With Newly Diagnosed 1p/19q Codeleted Anaplastic Oligodendroglial Tumors: the POLCA Trial.
A Randomized Trial of Delayed Radiotherapy in Patients With Newly Diagnosed 1p/19q Codeleted Anaplastic Oligodendroglial Tumors: the POLCA Trial.
Enrollment Status: Completed
Publish Date: January 23, 2026
Intervention Type: Drug
Study Drugs: PCV Chemotherapy Alone, Radiotherapy+PCV Chemotherapy
Study Phase: Phase 3
Role of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Patients Wih Leptomeningeal Metastasis of Breast Cancer. A Randomized Phase III Study.
Role of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Patients Wih Leptomeningeal Metastasis of Breast Cancer. A Randomized Phase III Study.
Enrollment Status: Completed
Publish Date: June 12, 2019
Intervention Type: Drug
Study Phase: Phase 3
An International, Randomized, Open-label Phase I/II Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas Presenting an Activation of the Sonic Hedgehog (SHH) Pathway
An International, Randomized, Open-label Phase I/II Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas Presenting an Activation of the Sonic Hedgehog (SHH) Pathway
Enrollment Status: Terminated
Publish Date: May 21, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

122 Total Publications

Late-onset vascular complications of radiotherapy for primary brain tumors: a case-control and cross-sectional analysis.
Late-onset vascular complications of radiotherapy for primary brain tumors: a case-control and cross-sectional analysis.
Journal: Journal of cancer survivorship : research and practice
Published: December 30, 2022

Frequently Asked Questions about Jean-yves Y. Delattre

Is Jean-yves Y. Delattre a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-yves Y. Delattre is classified as an Distinguished expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-yves Y. Delattre participate in research or clinical trials?

Yes. Jean-yves Y. Delattre has published 122 articles and abstracts on conditions like Glioma. You can view a list of Jean-yves Y. Delattre's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Delattre's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile